Imricor Medical Systems logo

Imricor Medical Systems(ASX) IMR

Market CapA$519.93MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)+3%
5 Year+21%
1 Year-0%
1 Month-21%
A$1.45
-0.35%
-0.01Today
Imricor Medical Systems last closing stock price
MetricPriceDate
Last closeAUD 1.452026-10-13
Imricor Medical Systems stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.36%AUD 1.482026-10-06
1 month-20.6%AUD 1.822026-09-11
3 month-13.47%AUD 1.672026-07-15
Year to date-5.56%AUD 1.532025-12-31
1 year-0.34%AUD 1.452025-10-13
3 year+210.75%AUD 0.472023-10-13
5 year+20.92%AUD 1.202021-10-14
Since inception+3.26%AUD 1.402019-08-30

Imricor Medical Systems Financials at a Glance

Market Cap

A$519.93MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$771.94K

Net Income (TTM)

-$66.94M

EPS (TTM)

-A$0.13

P/E Ratio

-11.35

Dividend

A$0.00

Beta (Volatility)

-0.37 (Low)

Price

A$1.45

Volume

425,755

Open

A$1.50

Previous Close

A$1.45

Daily Range

A$1.43 - A$1.50

52-Week Range

A$1.28 - A$2.25

Estimated Earnings Date

Dec 2, 2026

IMR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imricor Medical Systems

Imricor Medical Systems, Inc. is a medical device company specializing in MRI-compatible products for cardiac catheter ablation procedures. The company designs, manufactures, and distributes innovative solutions aimed at improving patient outcomes in the United States, Europe, and the Middle East.

Products and Services
  • Vision-MR Ablation Catheter 2.0 for cardiac ablation
  • NorthStar mapping system for high-resolution MRI imaging
  • Advantage-MR EP Recorder / Stimulator for electrophysiology procedures
Growth Outlook
  • Expanding market for MRI-compatible medical devices is projected to grow significantly
  • Increased adoption of cardiac ablation procedures enhances product demand
  • Strategic partnerships may accelerate market penetration and innovation
Financial Highlights
  • Recent quarterly revenue of 24,643, reflecting ongoing operational challenges
  • Trailing twelve months (TTM) revenue of 97,186 indicates potential for growth
  • Cash and cash equivalents of 60,539,147 provide liquidity for future investments
Imricor Medical Systems, Inc. operates in the healthcare sector, focusing on advanced medical technologies. The company’s innovative products are designed to enhance the safety and effectiveness of cardiac procedures, particularly in MRI environments. Despite facing operational challenges, the company has a solid cash position, which may support future growth initiatives. The expanding market for MRI-compatible devices and the increasing prevalence of cardiac procedures present significant opportunities for Imricor. Investors may find the company's strategic direction and product offerings compelling as it navigates the evolving landscape of medical technology.
AI Generated • Sep 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Steven Wedan

Website

www.imricor.com

Headquarters

Burnsville, MN 55337, US

IMR Financials

Key Financial Metrics (TTM)

Gross Margin

-2310.42%

Operating Margin

-22678.23%

Net Income Margin

-30813.40%

Return on Equity

-184.93%

Return on Capital

-62.90%

Return on Assets

-51.01%

Earnings Yield

-8.81%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$519.93MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

358.57M

Volume

425.75K

Avg. Volume

707.06K

Financials (TTM)

Gross Profit

-$3.51M

Operating Income

-$41.42M

EBITDA

-$39.52M

Operating Cash Flow

-$35.99M

Capital Expenditure

-$952.15K

Free Cash Flow

-$36.94M

Cash & ST Invst.

$67.46M

Total Debt

$34.02M

Imricor Medical Systems Performance Analysis

Imricor Medical Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,177,11326.9%
20232023-12-31USD 927,387-21.2%
20242024-12-31USD 1,454,55756.8%
20252025-12-31USD 453,323-68.8%
Imricor Medical Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3135.3%
Q22025-06-30-82.2%
Q42025-12-31-1.3%
Q22026-06-30-74.6%
Imricor Medical Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.17-14.5%
20232023-12-31USD -0.2226.7%
20242024-12-31USD -0.20-7.7%
20252025-12-31USD -0.13-36.7%
Imricor Medical Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-146.4%
Q22025-06-3075.0%
Q42025-12-31-73.9%
Q22026-06-30-107.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$24.64K

-94.0%

Gross Profit

-$1.37M

-153.7%

Gross Margin

-55.59%

N/A

Market Cap

A$519.93MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$6.67M

N/A

Employees

78

N/A

Net Income

-$25.14M

-266.6%

EBITDA

-$15.29M

-100.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$67.46M

+4387.7%

Total Debt

$34.02M

+261.2%

Accounts Receivable

$254.61K

-18.4%

Inventory

$1.35M

-27.6%

Long Term Debt

$524.03K

-94.1%

Short Term Debt

$33.50M

+5471.5%

Return on Assets

-51.01%

N/A

Return on Invested Capital

-83.73%

N/A

Free Cash Flow

-$14.63M

-81.7%

Operating Cash Flow

-$14.03M

-75.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,799.81-0.00%
^DJIDJI
$51,815.75+0.00%
^IXICNASDAQ
$27,233.87-0.00%
BTCBitcoin
$82,442.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.67-0.89%
INTCIntel
$101.35-3.20%
NOKNokia
$9.90-4.44%
NVDANvidia
$226.32-1.29%

Questions About IMR

What is the current price of Imricor Medical Systems?

Imricor Medical Systems is trading at A$1.45 per share.

What is the 52-week range for Imricor Medical Systems?

Over the past 52 weeks, Imricor Medical Systems has traded between A$1.28 and A$2.25.

How much debt does Imricor Medical Systems have?

As of the most recent reporting period, Imricor Medical Systems reported total debt of $49.11M.

How much cash does Imricor Medical Systems have on hand?

Imricor Medical Systems reported $67.06M in cash and cash equivalents in its most recent financial results.

What is Imricor Medical Systems’s dividend yield?

Imricor Medical Systems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services